# A Safety and Efficacy Study of CNTO1275 in Patients With Multiple Sclerosis

> **NCT00207727** · PHASE2 · COMPLETED · sponsor: **Centocor, Inc.** · enrollment: 249 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** CNTO 1275

## Key facts

- **NCT ID:** NCT00207727
- **Lead sponsor:** Centocor, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2006-03
- **Final completion:** 2006-08
- **Target enrollment:** 249 (ACTUAL)
- **Last updated:** 2012-04-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00207727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00207727, "A Safety and Efficacy Study of CNTO1275 in Patients With Multiple Sclerosis". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00207727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*